Evidence map›Paper›PMID 33912178›Full record

Observational studyFrontiers in immunology2021

Regulatory B Cells Dysregulated T Cell Function in an IL-35-Dependent Way in Patients With Chronic Hepatitis B.

YaYun Liu, Ying Luo, Tong Zhu, Meng Jiang, ZhaoFeng Tian, GuSheng Tang, XueSong Liang

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03734783 (Regulate Effect of Il-35 Secreting Breg Cells on Tcells and on Diseases Progression in Patients With CHB), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03734783 completednot on this map

Regulate Effect of Il-35 Secreting Breg Cells on Tcells and on Diseases Progression in Patients With CHB

Typeobservational_patient_registrySponsorChanghai HospitalRan2017 to 2019Enrolled55ConditionsChronic Hepatitis b
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. The circulating IL-35Immunity, inflammation and disease · 2024
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2021
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

YaYun LiuDepartment of Infectious Diseases, Changhai Hospital, Navy Military Medical University, Shanghai, China.
Ying LuoDepartment of Clinical Experiment Center, Changhai Hospital, Navy Military Medical University, Shanghai, China.
Tong ZhuDepartment of Infectious Diseases, Changhai Hospital, Navy Military Medical University, Shanghai, China.
Meng JiangDepartment of Infectious Diseases, Changhai Hospital, Navy Military Medical University, Shanghai, China.
ZhaoFeng TianDepartment of Laboratory Diagnostics, Changhai Hospital, Navy Military Medical University, Shanghai, China.
GuSheng TangDepartment of Hematology Laboratory Center, Changhai Hospital, Navy Military Medical University, Shanghai, China.
XueSong LiangDepartment of Infectious Diseases, Changhai Hospital, Navy Military Medical University, Shanghai, China.
Second Military Medical University · CNChanghai Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin (IL)-35-secreting B (IL-35+B) cells are critical regulators in autoimmune and infectious diseases and exert suppressive functions in parallel with IL-10-producing B (B10) cells. However, the role of IL-35+B cells in persistent hepatitis B virus (HBV) infection remains unclear. To elucidate the role of IL-35+B cells in the progress of chronic HBV infection, we determined the frequency of IL-35+B cells and their relationship with the classical human regulatory B cell (Breg) subsets, namely, CD19+CD24 Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03734783.

Indexed as

AdultB-Lymphocytes, RegulatoryCase-Control StudiesCell CommunicationCross-Sectional StudiesFemaleHealthy VolunteersHepatitis B, ChronicHepatitis B virusHumansInterleukinsMaleT-LymphocytesYoung Adultinterleukin-35, humanInterleukinschronic HBV infectionHBV - hepatitis B virusIL-35-secreting B (IL-35+B) cellsimmune regulationinterleukin 35 (IL-35)regulatory B cells (Bregs)

Identifiers

PMID33912178
PMCPMC8072152
OpenAlexW3154260861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.